Hearing your views on a new contrast agent for MRI Breast screening
Categories: Patient or loved one
Share your views on a new, reduced dose of the contrast agent used in MRIs to help researchers understand what’s important to people receiving annual breast MRI screening.
What’s the project about?
Some women who are at a higher risk of developing breast cancer are eligible for annual MRI breast screening to help detect cancer earlier.
Contrast agents are used in MRI scans to improve the clarity of the image. A new contrast agent has recently been approved for use within the UK. This new agent contains half of the usual amount of its key ingredient used to be able to appear on MR images - gadolinium.
Modern contrast agents are generally considered safe, however there is a potential risk when used repeatedly over a long period of time.
Therefore, a reduced dose of the active ingredient could have benefits for people receiving regular MRIs.
Researchers are investigating this new contrast agent to see whether it’s as effective as other, stronger agents for breast imaging.
They want to hear from people who have regular MRIs about their thoughts on the new agent and the study.
Who’s organising it?
Name of project lead: Darren Hudson
Job title: Lecturer
Organisation: University of Exeter
Email address: d.hudson5@exeter.ac.uk
Who can take part?
You can take part if you are, or have been, eligible for annual breast MRI screening.
Why do you want me to be involved?
By sharing your experience of breast MRI screening and your opinions of the project, you can help the researchers better understand what’s important to people on the pathway. This will ensure that the priorities of people affected by breast cancer are reflected in the research and outcomes.
What will you ask me to do?
You'll be asked to give your feedback on the contrast agent and the possible benefits or drawbacks.
The researchers would also like to gather feedback on the study design, to make sure it's beneficial for and relevant to participants, when the study is underway.
You'll be able to share your experience of being on the MRI programme, and what would be important to you to look at in the study.
How do I get involved?
If you’re interested in taking part, or have any questions, you can email Darren at d.hudson5@exeter.ac.uk
When’s the deadline?
31 December 2024
Get involved
Share your thoughts on the new contrast agent and help to keep the priorities of people affected by breast cancer at the heart of the study and its outcomes.